vs

Side-by-side financial comparison of COASTAL FINANCIAL CORP (CCB) and Inspire Medical Systems, Inc. (INSP). Click either name above to swap in a different company.

Inspire Medical Systems, Inc. is the larger business by last-quarter revenue ($269.1M vs $138.0M, roughly 1.9× COASTAL FINANCIAL CORP). On growth, Inspire Medical Systems, Inc. posted the faster year-over-year revenue change (12.2% vs -5.8%). COASTAL FINANCIAL CORP produced more free cash flow last quarter ($246.1M vs $41.8M). Over the past eight quarters, Inspire Medical Systems, Inc.'s revenue compounded faster (28.1% CAGR vs -3.6%).

Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

CCB vs INSP — Head-to-Head

Bigger by revenue
INSP
INSP
1.9× larger
INSP
$269.1M
$138.0M
CCB
Growing faster (revenue YoY)
INSP
INSP
+18.0% gap
INSP
12.2%
-5.8%
CCB
More free cash flow
CCB
CCB
$204.3M more FCF
CCB
$246.1M
$41.8M
INSP
Faster 2-yr revenue CAGR
INSP
INSP
Annualised
INSP
28.1%
-3.6%
CCB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCB
CCB
INSP
INSP
Revenue
$138.0M
$269.1M
Net Profit
$136.1M
Gross Margin
86.6%
Operating Margin
12.4%
17.1%
Net Margin
50.6%
Revenue YoY
-5.8%
12.2%
Net Profit YoY
286.4%
EPS (diluted)
$0.84
$4.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCB
CCB
INSP
INSP
Q4 25
$138.0M
$269.1M
Q3 25
$144.7M
$224.5M
Q2 25
$119.4M
$217.1M
Q1 25
$139.5M
$201.3M
Q4 24
$146.5M
$239.7M
Q3 24
$151.1M
$203.2M
Q2 24
$135.3M
$195.9M
Q1 24
$148.4M
$164.0M
Net Profit
CCB
CCB
INSP
INSP
Q4 25
$136.1M
Q3 25
$13.6M
$9.9M
Q2 25
$11.0M
$-3.6M
Q1 25
$9.7M
$3.0M
Q4 24
$35.2M
Q3 24
$13.5M
$18.5M
Q2 24
$11.6M
$9.8M
Q1 24
$6.8M
$-10.0M
Gross Margin
CCB
CCB
INSP
INSP
Q4 25
86.6%
Q3 25
85.8%
Q2 25
84.0%
Q1 25
84.7%
Q4 24
85.0%
Q3 24
84.1%
Q2 24
84.8%
Q1 24
84.9%
Operating Margin
CCB
CCB
INSP
INSP
Q4 25
12.4%
17.1%
Q3 25
12.4%
4.3%
Q2 25
12.0%
-1.5%
Q1 25
8.4%
-0.7%
Q4 24
11.7%
13.3%
Q3 24
10.8%
7.0%
Q2 24
11.1%
2.6%
Q1 24
5.9%
-9.3%
Net Margin
CCB
CCB
INSP
INSP
Q4 25
50.6%
Q3 25
9.4%
4.4%
Q2 25
9.2%
-1.7%
Q1 25
7.0%
1.5%
Q4 24
14.7%
Q3 24
8.9%
9.1%
Q2 24
8.6%
5.0%
Q1 24
4.6%
-6.1%
EPS (diluted)
CCB
CCB
INSP
INSP
Q4 25
$0.84
$4.57
Q3 25
$0.88
$0.34
Q2 25
$0.71
$-0.12
Q1 25
$0.63
$0.10
Q4 24
$0.95
$1.17
Q3 24
$0.97
$0.60
Q2 24
$0.84
$0.32
Q1 24
$0.50
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCB
CCB
INSP
INSP
Cash + ST InvestmentsLiquidity on hand
$308.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$491.0M
$781.2M
Total Assets
$4.7B
$907.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCB
CCB
INSP
INSP
Q4 25
$308.3M
Q3 25
$322.6M
Q2 25
$300.9M
Q1 25
$369.2M
Q4 24
$445.5M
Q3 24
$411.0M
Q2 24
$439.7M
Q1 24
$441.4M
Stockholders' Equity
CCB
CCB
INSP
INSP
Q4 25
$491.0M
$781.2M
Q3 25
$475.3M
$666.5M
Q2 25
$461.7M
$677.8M
Q1 25
$449.9M
$635.7M
Q4 24
$438.7M
$689.7M
Q3 24
$331.9M
$696.6M
Q2 24
$316.7M
$638.1M
Q1 24
$303.7M
$589.0M
Total Assets
CCB
CCB
INSP
INSP
Q4 25
$4.7B
$907.3M
Q3 25
$4.6B
$807.7M
Q2 25
$4.5B
$802.2M
Q1 25
$4.3B
$730.8M
Q4 24
$4.1B
$808.4M
Q3 24
$4.1B
$796.2M
Q2 24
$4.0B
$728.4M
Q1 24
$3.9B
$685.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCB
CCB
INSP
INSP
Operating Cash FlowLast quarter
$254.6M
$52.5M
Free Cash FlowOCF − Capex
$246.1M
$41.8M
FCF MarginFCF / Revenue
178.3%
15.5%
Capex IntensityCapex / Revenue
6.1%
4.0%
Cash ConversionOCF / Net Profit
0.39×
TTM Free Cash FlowTrailing 4 quarters
$436.4M
$78.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCB
CCB
INSP
INSP
Q4 25
$254.6M
$52.5M
Q3 25
$59.0M
$68.5M
Q2 25
$66.0M
$2.7M
Q1 25
$71.7M
$-6.7M
Q4 24
$259.8M
$69.2M
Q3 24
$62.6M
$52.3M
Q2 24
$72.1M
$-78.0K
Q1 24
$56.8M
$8.9M
Free Cash Flow
CCB
CCB
INSP
INSP
Q4 25
$246.1M
$41.8M
Q3 25
$57.4M
$58.1M
Q2 25
$64.0M
$-6.3M
Q1 25
$68.9M
$-15.1M
Q4 24
$249.9M
$62.2M
Q3 24
$60.2M
$44.3M
Q2 24
$69.5M
$-12.5M
Q1 24
$55.0M
$-2.8M
FCF Margin
CCB
CCB
INSP
INSP
Q4 25
178.3%
15.5%
Q3 25
39.7%
25.9%
Q2 25
53.6%
-2.9%
Q1 25
49.4%
-7.5%
Q4 24
170.6%
25.9%
Q3 24
39.8%
21.8%
Q2 24
51.3%
-6.4%
Q1 24
37.1%
-1.7%
Capex Intensity
CCB
CCB
INSP
INSP
Q4 25
6.1%
4.0%
Q3 25
1.2%
4.6%
Q2 25
1.7%
4.1%
Q1 25
2.0%
4.2%
Q4 24
6.8%
2.9%
Q3 24
1.6%
3.9%
Q2 24
1.9%
6.3%
Q1 24
1.2%
7.1%
Cash Conversion
CCB
CCB
INSP
INSP
Q4 25
0.39×
Q3 25
4.34×
6.90×
Q2 25
5.99×
Q1 25
7.37×
-2.24×
Q4 24
1.96×
Q3 24
4.65×
2.83×
Q2 24
6.22×
-0.01×
Q1 24
8.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCB
CCB

Other$74.7M54%
Baa S Credit Enhancements$47.3M34%
Baa S Program Income$8.4M6%
Transaction Fees$4.9M4%
Servicing And Other Baa S Fees$1.6M1%
Baa S Fraud Enhancements$1.1M1%

INSP
INSP

Segment breakdown not available.

Related Comparisons